Clinical Trial Update: Hemodynamic and Echocardiographic Assessment of Riociguat Effects on Myocardial Wall Contractility and Relaxation Kinetics [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating riociguat's effects on hemodynamics and left-ventricular contractility/relaxation in patients with pulmonary hypertension and left vent…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Left Ventricular Dysfunction
• Pulmonary Hypertension

Drugs mentioned

• Riociguat (riociguat)

Snippet

Sponsor: Bayer | Conditions: Hypertension, Pulmonary, Ventricular Dysfunction, Left | Phase 2 | Status: TERMINATED | Results posted: 2014-01-06